EBF:NYSEEnnis, Inc. Analysis
Data as of 2026-09-01 - not real-time
$21.26
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Ennis, Inc. trades at $21.26, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. RSI sits at 38.6, which reads as approaching oversold, and MACD momentum is bearish. Price has been bracketed by support at $21.22 and resistance at $22.94.
The shares look undervalued, trading on 12.7 times earnings below a sector average of 28.8. The average analyst target implies 12.9% above today's level. The 4.65% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 13.5%, a beta of 0.12 and a maximum drawdown of 12.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.
The shares look undervalued, trading on 12.7 times earnings below a sector average of 28.8. The average analyst target implies 12.9% above today's level. The 4.65% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 13.5%, a beta of 0.12 and a maximum drawdown of 12.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 20.29
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 12.7 versus sector average of 28.8
- Trading above the 200-day average of 20.29
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- P/E of 12.7 versus sector average of 28.8
- Analyst targets imply +12.9% versus the current price
- Dividend yield of 4.65%
Key Metrics & Analysis
Financial Health
Revenue Growth1.50%
Profit Margin10.84%
P/E Ratio12.7
ROE13.96%
ROA8.92%
Debt/Equity2.59
P/B Ratio1.7
Op. Cash Flow$66.0M
Free Cash Flow$45.7M
Industry P/E28.8
Technical Analysis
TrendBullish
RSI38.6
Support$21.22
Resistance$22.94
MA 20$21.90
MA 50$21.64
MA 200$20.29
MACDBearish
VolumeIncreasing
Fear & Greed Index93.07
Valuation
Fair Value$26.18
Target Price$24.00
Upside/Downside12.89%
GradeUndervalued
TypeValue
Dividend Yield4.65%
Risk Assessment
Beta0.12
Volatility13.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.